Aarti Pharma Labs

786.80
-14.90
(-1.86%)
Market Cap
7,130.45 Cr
EPS
23.93
PE Ratio
29.17
Dividend Yield
0.37 %
Industry
Healthcare
52 Week High
837.25
52 Week low
399.55
PB Ratio
3.92
Debt to Equity
0.15
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,669.30 4,00,520.99 34.13 49,887.20 12.06 9,648 13.77 37.74
5,978.30 1,58,705.08 76.14 8,184.00 0.89 1,600 64.53 51.57
1,479.70 1,19,502.65 23.70 26,520.70 14.17 4,155 47.38 51.15
3,095.95 1,04,781.02 56.64 10,785.70 11.59 1,656 13.54 45.77
1,170.95 97,705.34 18.09 28,905.40 12.36 5,578 1.69 30.83
2,348.45 96,889.27 47.77 10,615.60 19.57 1,942 -16.38 39.42
899.65 90,525.84 19.78 19,831.50 13.82 3,831 29.92 36.77
1,977.50 90,213.07 31.46 20,141.50 19.94 1,936 38.82 38.83
1,121.25 65,122.38 18.72 29,559.20 17.55 3,169 -10.04 42.81
29,429.65 62,535.95 47.37 6,097.20 10.80 1,201 16.01 61.56
Growth Rate
Revenue Growth
-4.63 %
Net Income Growth
12.09 %
Cash Flow Change
-13.50 %
ROE
-0.64 %
ROCE
-1.87 %
EBITDA Margin (Avg.)
19.06 %

Quarterly Financial Results

Quarterly Financials
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
463
457
532
472
486
459
441
450
508
558
463
543
Expenses
385
371
441
385
405
374
352
353
388
459
364
409
EBITDA
78
86
91
87
81
85
89
97
120
99
98
134
Operating Profit %
16 %
19 %
17 %
18 %
16 %
19 %
20 %
21 %
23 %
17 %
20 %
24 %
Depreciation
14
14
17
16
16
17
18
19
19
20
21
23
Interest
5
4
6
5
6
4
4
5
5
5
6
10
Profit Before Tax
60
68
69
65
59
64
67
74
96
74
72
101
Tax
11
16
18
17
16
17
15
21
31
18
17
27
Net Profit
49
52
51
48
43
47
52
53
65
56
55
74
EPS in ₹
5.39
5.72
5.64
5.26
4.73
5.20
5.72
5.82
7.20
6.12
6.03
8.16

Balance Sheet

Balance Sheet
2021
2022
2023
2024
Total Assets
0
2,040
2,244
2,582
Fixed Assets
0
782
926
1,033
Current Assets
0
1,028
1,163
1,346
Capital Work in Progress
0
187
102
137
Investments
0
32
87
107
Other Assets
0
1,038
1,130
1,305
Total Liabilities
0
2,040
2,244
2,582
Current Liabilities
0
581
601
694
Non Current Liabilities
0
73
85
131
Total Equity
0
1,387
1,559
1,757
Reserve & Surplus
0
1,341
1,513
1,712
Share Capital
0
0
45
45

Cash Flow

Cash Flow
2021
2022
2023
2024
Net Cash Flow
0
78
-71
12
Investing Activities
0
-139
-158
-215
Operating Activities
0
-44
250
216
Financing Activities
0
260
-164
10

Share Holding

% Holding
Jan 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
44.16 %
45.98 %
45.98 %
46.30 %
46.46 %
46.46 %
46.46 %
46.10 %
44.66 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
8.16 %
8.32 %
7.06 %
7.38 %
8.64 %
DIIs
14.73 %
13.70 %
10.66 %
10.51 %
9.91 %
9.97 %
11.47 %
11.35 %
10.36 %
Government
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
Public / Retail
24.66 %
28.35 %
30.23 %
29.13 %
29.74 %
29.71 %
29.57 %
29.45 %
30.39 %
Others
16.44 %
11.96 %
13.12 %
14.04 %
5.72 %
5.52 %
5.43 %
5.71 %
5.94 %
No of Share Holders
3,05,456
2,76,664
2,58,236
2,26,286
2,15,796
2,04,122
1,89,012
1,85,436
1,85,111

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2 3 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.46 0.37 0.00

Corporate Action

Technical Indicators